BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28121436)

  • 1. Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms.
    Sedghizadeh PP; Sun S; Junka AF; Richard E; Sadrerafi K; Mahabady S; Bakhshalian N; Tjokro N; Bartoszewicz M; Oleksy M; Szymczyk P; Lundy MW; Neighbors JD; Russell RG; McKenna CE; Ebetino FH
    J Med Chem; 2017 Mar; 60(6):2326-2343. PubMed ID: 28121436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen
    Sedghizadeh PP; Cherian P; Roshandel S; Tjokro N; Chen C; Junka AF; Hu E; Neighbors J; Pawlak J; Russell RGG; McKenna CE; Ebetino FH; Sun S; Sodagar E
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in experimental models of osteomyelitis.
    Cassat JE; Skaar EP
    Expert Rev Anti Infect Ther; 2013 Dec; 11(12):1263-5. PubMed ID: 24215241
    [No Abstract]   [Full Text] [Related]  

  • 4. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
    Monzón M; García-Alvarez F; Laclériga A; Gracia E; Leiva J; Oteiza C; Amorena B
    J Orthop Res; 2001 Sep; 19(5):820-6. PubMed ID: 11562127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Bisphosphonate-Conjugated Sitafloxacin in a Murine Model of
    Ren Y; Xue T; Rainbolt J; Bentley KLM; Galloway CA; Liu Y; Cherian P; Neighbors J; Hofstee MI; Ebetino FH; Moriarty TF; Sun S; Schwarz EM; Xie C
    Front Cell Infect Microbiol; 2022; 12():910970. PubMed ID: 35811672
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Characterization of Bone Binding Antibiotic-1 (BBA-1), a Novel Antimicrobial for Orthopedic Applications.
    Kamble S; Valtchev P; Dao A; Pelras T; Rogers MJ; Savage PB; Dehghani F; Schindeler A
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
    Gracia E; Laclériga A; Monzón M; Leiva J; Oteiza C; Amorena B
    J Surg Res; 1998 Oct; 79(2):146-53. PubMed ID: 9758730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental osteomyelitis by liposomal antibiotics.
    Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA
    J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.
    Mader JT; Morrison LT; Adams KR
    Antimicrob Agents Chemother; 1987 Feb; 31(2):259-63. PubMed ID: 3566251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
    Koort JK; Mäkinen TJ; Suokas E; Veiranto M; Jalava J; Knuuti J; Törmälä P; Aro HT
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1502-8. PubMed ID: 15793132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro biofilm model of Staphylococcus aureus infection of bone.
    Sweeney E; Lovering AM; Bowker KE; MacGowan AP; Nelson SM
    Lett Appl Microbiol; 2019 Apr; 68(4):294-302. PubMed ID: 30770577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallic nanoparticles to eradicate bacterial bone infection.
    Qadri S; Haik Y; Mensah-Brown E; Bashir G; Fernandez-Cabezudo MJ; Al-Ramadi BK
    Nanomedicine; 2017 Oct; 13(7):2241-2250. PubMed ID: 28599795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis.
    García-Alvarez F; Monzón M; Grasa JM; Laclériga A; Amorena B; García-Alvarez I; Navarro-Zorraquino M; Alvarez FG
    J Orthop Sci; 2006 Jul; 11(4):370-4. PubMed ID: 16897201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-eluting hydrophilized PMMA bone cement with prolonged bactericidal effect for the treatment of osteomyelitis.
    Oh EJ; Oh SH; Lee IS; Kwon OS; Lee JH
    J Biomater Appl; 2016 May; 30(10):1534-44. PubMed ID: 26847915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic delivery from bone-targeted mesoporous silica nanoparticles for the treatment of osteomyelitis caused by methicillin-resistant Staphylococcus aureus.
    Aguilera-Correa JJ; Gisbert-Garzarán M; Mediero A; Fernández-Aceñero MJ; de-Pablo-Velasco D; Lozano D; Esteban J; Vallet-Regí M
    Acta Biomater; 2022 Dec; 154():608-625. PubMed ID: 36341887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis.
    Tanaka KS; Dietrich E; Ciblat S; Métayer C; Arhin FF; Sarmiento I; Moeck G; Parr TR; Far AR
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1355-9. PubMed ID: 20097069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the targeted theragnostics of osteomyelitis caused by Staphylococcus aureus.
    Abdulrehman T; Qadri S; Haik Y; Sultan A; Skariah S; Kumar S; Mendoza Z; Yadav KK; Titus A; Khader S
    Arch Microbiol; 2024 Jun; 206(7):288. PubMed ID: 38834761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antibacterial activity and cytocompatibility of ciprofloxacin loaded gelatin-hydroxyapatite scaffolds as a local drug delivery system for osteomyelitis treatment.
    Krishnan AG; Jayaram L; Biswas R; Nair M
    Tissue Eng Part A; 2015 Apr; 21(7-8):1422-31. PubMed ID: 25567452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-ciprofloxacin bound to Skelite is a prototype for enhancing experimental local antibiotic delivery to injured bone.
    Buxton TB; Walsh DS; Harvey SB; McPherson JC; Hartmann JF; Plowman KM
    Br J Surg; 2004 Sep; 91(9):1192-6. PubMed ID: 15449273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.